| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $300.7M | +24.2% |
| Cost of Revenue | $97.6M | +24.6% |
| Gross Profit | $203.1M | +24.0% |
| R&D Expense | $104.9M | +10.9% |
| SG&A Expense | $71.6M | +21.2% |
| Operating Income | -$126.9M | -4.6% |
| Interest Expense | $173K | -0.6% |
| Pre-tax Income | -$122.0M | -0.5% |
| Income Tax | $2.8M | +45.8% |
| Net Income | -$124.8M | -1.2% |
| EPS (Basic) | -$1.06 | +6.2% |
| EPS (Diluted) | -$1.06 | +6.2% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76.5M | -4.4% |
| Accounts Receivable | $58.4M | +18.0% |
| Current Assets | $391.8M | +5.9% |
| Total Assets | $579.1M | -3.8% |
| Current Liabilities | $196.2M | +16.0% |
| Total Liabilities | $204.0M | +11.4% |
| Stockholders' Equity | $375.1M | -10.5% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.4M | +10.3% |
| Capital Expenditures | $386K | -82.9% |
| Investing Cash Flow | $6.3M | +101.9% |
| Financing Cash Flow | $18.7M | -38.1% |
| Free Cash Flow | -$27.7M | +15.3% |